- Home
- NERV vs JELD Comparison
NERV vs JELD Comparison
Compare NERV & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NERV | JELD |
|---|---|---|
| Founded | 2007 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Forest Products |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.4M | 152.7M |
| IPO Year | 2014 | 2016 |
Fundamental Metrics
Financial Performance| Metric | NERV | JELD |
|---|---|---|
| Price | $2.31 | $1.37 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $10.33 | $1.93 |
| AVG Volume (30 Days) | 105.4K | ★ 1.5M |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $41,175,600.00 | ★ $3,211,181,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.24 | $0.93 |
| 52 Week High | $8.80 | $4.90 |
Technical Indicators
Market Signals| Indicator | NERV | JELD |
|---|---|---|
| Relative Strength Index (RSI) | 27.35 | 41.39 |
| Support Level | N/A | $1.36 |
| Resistance Level | $5.69 | $2.25 |
| Average True Range (ATR) | 0.26 | 0.14 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 4.83 | 28.03 |
Price Performance
Historical ComparisonAbout NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.